Company Filing History:
Years Active: 2004-2006
Title: Innovations by Tomokazu Sugi in Sustained-Release Preparations
Introduction
Tomokazu Sugi is a notable inventor based in Shizuoka-ken, Japan. He has made significant contributions to the field of pharmaceutical preparations, particularly in the development of oral sustained-release formulations. With a total of two patents to his name, Sugi's work focuses on improving patient compliance and therapeutic efficacy.
Latest Patents
Sugi's latest patents include a process for producing an oral sustained-release preparation of fasudil hydrochloride. This innovative preparation contains at least one active ingredient selected from fasudil hydrochloride and its hydrates. The formulation comprises sustained-release coated particles, which allow for controlled release of the active ingredient over an extended period. This advancement not only enhances the therapeutic effect but also reduces the burden on patients who need to take the medication regularly. Additionally, Sugi has developed a method for evaluating the sustained-release ability of such oral preparations, ensuring their effectiveness in clinical applications.
Career Highlights
Tomokazu Sugi is currently associated with Asahi Kasei Pharma Corporation, where he continues to innovate in the pharmaceutical sector. His work has been instrumental in advancing drug delivery systems, particularly those that require sustained release mechanisms. Sugi's contributions have been recognized within the industry, highlighting his role as a key figure in pharmaceutical research and development.
Collaborations
In his professional